Log in to save to my catalogue

Molecular Subtyping and Therapeutic Targeting of IFNG‐Driven Immunogenic Cell Death in Lung Adenocar...

Molecular Subtyping and Therapeutic Targeting of IFNG‐Driven Immunogenic Cell Death in Lung Adenocar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6928dd344fbf469d8736755e490dfaa9

Molecular Subtyping and Therapeutic Targeting of IFNG‐Driven Immunogenic Cell Death in Lung Adenocarcinoma

About this item

Full title

Molecular Subtyping and Therapeutic Targeting of IFNG‐Driven Immunogenic Cell Death in Lung Adenocarcinoma

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2025-02, Vol.14 (4), p.e70678-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

ABSTRACT
Background
Immunogenic cell death (ICD) can be triggered by various therapies to induce anti‐tumor immune responses, significantly enhancing treatment effectiveness, and is widely utilized in tumor immunotherapy.
Methods
LUAD data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) validated ICD‐related molecu...

Alternative Titles

Full title

Molecular Subtyping and Therapeutic Targeting of IFNG‐Driven Immunogenic Cell Death in Lung Adenocarcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6928dd344fbf469d8736755e490dfaa9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6928dd344fbf469d8736755e490dfaa9

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.70678

How to access this item